DSS, Inc. (DSS)
After hours:
| Previous Close | 1.7800 |
| Open | 1.7600 |
| Bid | 1.7200 x 900 |
| Ask | 1.7500 x 800 |
| Day's Range | 1.7400 - 1.7600 |
| 52 Week Range | 1.6450 - 9.3600 |
| Volume | |
| Avg. Volume | 11,369 |
| Market Cap | 12.367M |
| Beta (5Y Monthly) | 1.69 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4,608.0000 |
| Earnings Date | May 13, 2024 - May 17, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 27.60 |
GlobeNewswireImpact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled "Low Glycemic Sugar Composition" developed within this platform. The Laetose™ technology demonstrates compelling potential in reducing caloric intake and glycemic index in foods, whi
- GlobeNewswire
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in CompanyNEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the Board, Heng Fai Ambrose Chan. In a strategic move to bolster shareholder confidence and underscore his commitment to the company’s growth. Chairman Chan acquired an additional 672,1
- GlobeNewswire
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock split (the “Reverse Split”) of its issued and outstanding shares of common stock, par value $0.02, following authorization by its Board of Directors and majority
